Rearrangement and expression of MDM2 oncogene in chronic lymphocytic leukemia
- 1 October 1994
- journal article
- research article
- Published by Wiley in American Journal of Hematology
- Vol. 47 (2) , 139-141
- https://doi.org/10.1002/ajh.2830470215
Abstract
Since trisomy 12 is the most common chromosome abnormality found in CLL and MDM2 has been mapped to this chromosome, we examined the possible association of MDM2 in the pathogenesis of CLL. A rearrangement of the MDM2 gene was observed in 4 of 11 peripheral blood mononuclear cells (PBMC) from patients with CLL by Southern biot hybridization. Expression of MDM2 was detected in all of the CLL samples examined by Northern blot. However, neither gross amplification nor overexpression of the MDM2 gene was found in CLL. The data suggest that MDM2 may play a role in the pathogenesis of CLL and may help to explain how abnormalities of chromosome 12 are related to CLL.Keywords
This publication has 9 references indexed in Scilit:
- The human MDM-2 oncogene is overexpressed in leukemiasBlood, 1993
- Expression of int-2 oncogene in Kaposi's sarcoma lesions.Journal of Clinical Investigation, 1993
- The mdm-2 oncogene can overcome wild-type p53 suppression of transformed cell growth.Molecular and Cellular Biology, 1993
- Amplification of a gene encoding a p53-associated protein in human sarcomasNature, 1992
- Mutations of the p53 gene in adult T-cell leukemiaBlood, 1992
- p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia.Proceedings of the National Academy of Sciences, 1991
- Mutations of the p53 gene in lymphoid leukemiaBlood, 1991
- Prognostic Subgroups in B-Cell Chronic Lymphocytic Leukemia Defined by Specific Chromosomal AbnormalitiesNew England Journal of Medicine, 1990
- Consistency of chromosomal aberrations in chronic B-lymphocytic leukemia. A longitudinal cytogenetic study of 41 patientsCancer, 1988